Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Drug Research
Return to: PBR Home | Drug Research
Today in Drug Research

Drug Research

TG Therapeutics, Ligand ink licensing deal to develop inhibitors of IRAK4 US-based clinical-stage biopharmaceutical firm TG Therapeutics has entered into an agreement with Ligand Pharmaceuticals (LGND) to license exclusive global rights to develop and commercialize Ligand's Interleukin-1 Receptor Associated Kinase 4 (IRAK4) inhibitor research program. Drug Research > Drug Discovery & Development > News

Latest Drug Research News by Sector

Select a sector from the list or browse by sector below:

Drug Delivery

GlaxoSmithKline files regulatory application in Europe for malaria vaccine
By PBR Staff Writer
British drug-maker GlaxoSmithKline (GSK) has submitted a regulatory application to the European Medicines Agency (EMA) for its malaria vaccine candidate, RTS,S.
Drug Research > Drug Delivery > News
FDA approves Eagle's malignant hyperthermia treatment Ryanodex
By PBR Staff Writer
The US Food and Drug Administration (FDA) has approved Eagle Pharmaceuticals' Ryanodex (dantrolene sodium) for injectable suspension to treat malignant hyperthermia (MH), along with the appropriate supportive measures.
Drug Research > Drug Delivery > News

Drug Discovery & Development

Prometic Biosciences enters into new product development program
By PBR Staff Writer
ProMetic Life Sciences' UK subsidiary has signed an agreement with one of its existing multinational clients, a global leader in the biotherapeutics industry.
Drug Research > Drug Discovery & Development > News
National Institute of Allergy and Infectious Diseases awards SRI International Contract to study new therapies for HIV and AIDS
SRI International has been awarded a new $49 million, seven-year contract with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to conduct preclinical development of potential therapies for HIV infection and AIDS.
Drug Research > Drug Discovery & Development > News